Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Unofficial Trials

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jul 16, 2024 1:05pm

152 Views

Post# 36135009

RE:Unofficial Trials

So you want to bypass first world safety standards for people in poor countries.

Tarbaby wrote: Can a small company with limited funds do a few human trials in a third world country.
At least to prove a concept works.
Perhsps do in patients that have cancer and no further options .
Just thinking..

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December